Sigyn Therapeutics
sigyntherapeutics.com
Public Health & Prevention
Immunology & Inflammation Therapeutics
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Overview
We are developing medical devices to treat cancer and infectious disease disorders. Our lineup of therapeutic candidates is among the most expansive in the field of extracorporeal blood purification.
News
Sigyn Therapeutics Looking to Reduce Effects of Cytokine Storm With Blood Purification Technology Contagion Live
The company's current investigational medical device, Sigyn Therapy, is a novel medical device that is being studied for addressing viral pathogens and bacterial toxins to avoid this massive inflammation onslaught and the potential of sepsis.
Read more
Report
Report
Oragenics Signs Letter of Intent to License CardioDialysis Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
Read more
Report
Sigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTE
Read more
Report
CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events
Read more
Report
Scientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory Diseases
Read more
Report
Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives
Read more
Report
Show more news